Connection

PAOLO ANDERLINI to Hematopoietic Stem Cells

This is a "connection" page, showing publications PAOLO ANDERLINI has written about Hematopoietic Stem Cells.
Connection Strength

0.877
  1. Marginal keratitis associated with administration of filgrastim and sargramostim in a healthy peripheral blood progenitor cell donor. Cornea. 2002 Aug; 21(6):621-2.
    View in: PubMed
    Score: 0.128
  2. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood. 2001 Nov 15; 98(10):2900-8.
    View in: PubMed
    Score: 0.122
  3. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant. 2001 Apr; 27(7):689-92.
    View in: PubMed
    Score: 0.117
  4. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion. 1997 May; 37(5):507-12.
    View in: PubMed
    Score: 0.089
  5. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation. Bone Marrow Transplant. 1996 Dec; 18(6):1073-9.
    View in: PubMed
    Score: 0.087
  6. Peripheral blood stem cell apheresis in normal donors: the neglected side. Blood. 1996 Nov 01; 88(9):3663-4.
    View in: PubMed
    Score: 0.086
  7. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation. Blood. 2015 May 07; 125(19):2885-92.
    View in: PubMed
    Score: 0.077
  8. Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma. Br J Haematol. 2006 Jun; 133(5):533-7.
    View in: PubMed
    Score: 0.042
  9. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion. 1999 Jun; 39(6):555-60.
    View in: PubMed
    Score: 0.026
  10. Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system. Cytotherapy. 1999; 1(2):111-7.
    View in: PubMed
    Score: 0.025
  11. Collection of peripheral blood stem cells from normal donors 60 years of age or older. Br J Haematol. 1997 May; 97(2):485-7.
    View in: PubMed
    Score: 0.022
  12. Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors. Transfusion. 1997 Apr; 37(4):406-10.
    View in: PubMed
    Score: 0.022
  13. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood. 1995 Oct 01; 86(7):2842-8.
    View in: PubMed
    Score: 0.020
  14. Diagnosis and monitoring of primary cytomegalovirus infection by antigenemia test. Bone Marrow Transplant. 2002 Sep; 30(6):411.
    View in: PubMed
    Score: 0.008
  15. Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors. Bone Marrow Transplant. 1996 Nov; 18(5):885-90.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.